CTMX
Price
$0.50
Change
-$0.04 (-7.41%)
Updated
Apr 4, 11:09 AM (EDT)
Capitalization
43.5M
33 days until earnings call
IMAB
Price
$0.73
Change
-$0.05 (-6.41%)
Updated
Apr 3 closing price
Capitalization
59.5M
54 days until earnings call
Ad is loading...

CTMX vs IMAB

Header iconCTMX vs IMAB Comparison
Open Charts CTMX vs IMABBanner chart's image
CytomX Therapeutics
Price$0.50
Change-$0.04 (-7.41%)
Volume$4.2K
Capitalization43.5M
I-MAB
Price$0.73
Change-$0.05 (-6.41%)
Volume$229.73K
Capitalization59.5M
CTMX vs IMAB Comparison Chart
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. IMAB commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Buy and IMAB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CTMX: $0.54 vs. IMAB: $0.73)
Brand notoriety: CTMX and IMAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 62% vs. IMAB: 100%
Market capitalization -- CTMX: $43.5M vs. IMAB: $59.5M
CTMX [@Biotechnology] is valued at $43.5M. IMAB’s [@Biotechnology] market capitalization is $59.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileIMAB’s FA Score has 0 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • IMAB’s FA Score: 0 green, 5 red.
According to our system of comparison, CTMX is a better buy in the long-term than IMAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 5 TA indicator(s) are bullish while IMAB’s TA Score has 4 bullish TA indicator(s).

  • CTMX’s TA Score: 5 bullish, 3 bearish.
  • IMAB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CTMX is a better buy in the short-term than IMAB.

Price Growth

CTMX (@Biotechnology) experienced а -11.92% price change this week, while IMAB (@Biotechnology) price change was -13.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.49%. For the same industry, the average monthly price growth was -15.37%, and the average quarterly price growth was -17.15%.

Reported Earning Dates

CTMX is expected to report earnings on May 07, 2025.

IMAB is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-9.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMAB($59.5M) has a higher market cap than CTMX($43.5M). IMAB YTD gains are higher at: -14.106 vs. CTMX (-47.272). CTMX has higher annual earnings (EBITDA): 26.8M vs. IMAB (-212.17M). IMAB has more cash in the bank: 184M vs. CTMX (101M). IMAB has less debt than CTMX: IMAB (3.78M) vs CTMX (9.39M). CTMX has higher revenues than IMAB: CTMX (138M) vs IMAB (3.27M).
CTMXIMABCTMX / IMAB
Capitalization43.5M59.5M73%
EBITDA26.8M-212.17M-13%
Gain YTD-47.272-14.106335%
P/E Ratio1.43N/A-
Revenue138M3.27M4,216%
Total Cash101M184M55%
Total Debt9.39M3.78M248%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTMXIMAB
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INZY0.88-0.05
-5.49%
Inozyme Pharma
STAG34.16-2.01
-5.56%
Stag Industrial
RLAY2.29-0.20
-8.03%
Relay Therapeutics
LRCX65.22-8.56
-11.60%
Lam Research Corp
VSH12.45-3.48
-21.85%
Vishay Intertechnology

IMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMAB has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMAB jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMAB
1D Price
Change %
IMAB100%
-6.19%
VCYT - IMAB
43%
Loosely correlated
-5.51%
CTMX - IMAB
32%
Poorly correlated
-10.78%
RAPT - IMAB
31%
Poorly correlated
-4.31%
ARRY - IMAB
31%
Poorly correlated
-10.32%
AXON - IMAB
29%
Poorly correlated
-3.35%
More